An Investigation of How Institutional and State Characteristics Influence Community College Award Rates

Community colleges are an essential element of the American postsecondary landscape and workforce preparation. In 2017, over six-million students, which represented roughly one-third of the total undergraduate enrollment in the United States, were enrolled in community colleges. In the past ten years, the importance of community colleges in the economic need for greater postsecondary credential attainment has been underscored by state policies and national initiatives. The wide variation in both the nature of community colleges and the students they serve makes examining the outcomes of these institutions difficult and oftentimes imprecise. Assessing the performance of community colleges and determining what factors positively or negatively relate to their outcomes remains incompletely investigated. Statistical models of community college outcomes have failed to account for the distinctive characteristics of community colleges and have studied these institutions in isolation from their environments. Many of the limitations within literature may be attributed to insufficient data availability at the times of those studies. Adequate data, however, have recently become available that allow for the exploration of community college outcomes in a deeper and more meaningful way. This dissertation study investigated how institutional and state characteristics of community colleges determine award rates. This was accomplished by accounting for salient variables, by leveraging three national datasets, and by using a more appropriate analytical method for the study of community colleges at the national level. The results of ordinary least squares and multilevel regressions revealed variation between the institutional characteristics that significantly predict community college award rates once differences between states are taken into consideration. Moreover, variation was also observed in the institutional characteristics that significantly predict the award rates for all entering, first-time, and not-first-time students. In general, however, degree of urbanization, institutional type, and the proportions of part-time students, non-degree-seeking students, racial minority students, and female students emerged as consistent significant predictors across all statistical models

Recent Decisions

Comments on recent decisions by Harry D. Snyder, John A. Vuono, Leonard J. Kamer, John A. Young, Allan C. Schmid, William B. McFadden, David N. McBride, and Thomas J. Griffin

Do soldiers seek more mental health care after deployment? Analysis of mental health consultations in the Netherlands Armed Forces following deployment to Afghanistan

Background: Military deployment to combat zones puts military personnel to a number of physical and mental challenges that may adversely affect mental health. Until now, few studies have been performed in Europe on mental health utilization after military deployment. Objective: We compared the incidence of mental health consultations with the Military Mental Health Service (MMHS) of military deployed to Afghanistan to that of non-deployed military personnel. Method: We assessed utilization of the MMHS by the full cohort of the Netherlands Armed Forces enlisted between 2008 and 2010 through linkage of mental health and human resource information systems. Results: The total population consisted of 50,508 military (18,233 deployed, 32,275 non-deployed), who accounted for 1,906 new consultations with the MMHS. The follow-up was limited to the first 2 years following deployment. We observed higher mental health care utilization in deployed vs. non-deployed military personnel; hazard ratio (HR), adjusted for sex, military branch and time in service, 1.84 [95% CI 1.61–2.11] in the first and 1.28 [1.09–1.49] in the second year after deployment. An increased risk of adjustment disorders (HR 2.59 [2.02–3.32] and 1.74 [1.30–2.32]) and of anxiety disorders (2.22 [1.52–3.25] and 2.28 [1.50–3.45]) including posttraumatic stress disorder (5.15 [2.55–10.40] and 5.28 [2.42–11.50]), but not of mood disorders (1.33 [0.90–1.97] and 1.11 [0.68–1.82]), was observed in deployed personnel in the first- and second-year post-deployment, respectively. Military personnel deployed in a unit with a higher risk of confrontation with potentially traumatic events had a higher HR (2.13 [1.84–2.47] and 1.40 [1.18–1.67]). Conclusions: Though absolute risk was low, in the first and second year following deployment to Afghanistan there was an 80 and 30% higher risk for mental health problems resulting in a consultation with the Dutch MMHS compared to military never deployed to Afghanistan. These observations underscore the need for an adequate mental health infrastructure for those returning from deployment

Synergistic effects of bombesin and epidermal growth factor on cancers.

Bombesin and gastrin-releasing peptide act as autocrine mitogens in various cancers. Bombesin antagonist RC-3095 inhibited growth in some cancers and slowed the progression of premalignant lesions, possibly by down-regulating epidermal growth factor (EGF) receptors. Since the EGF receptor mitogen response involves tyrosine kinase stimulation, we tested the hypotheses that bombesin stimulates, and RC-3095 inhibits, phosphorylation; EGF and bombesin promote the phosphorylation of the same substrates; and EGF and bombesin act synergistically on phosphorylation. Therefore, in vitro assays for phosphorylation were performed in the presence or absence of EGF, bombesin, RC-3095, and combinations in samples derived from tumor, tissue surrounding tumor, cell lines, and normal and transforming tissue derived from the 9,10-dimethyl-1,2-benzanthracene-induced squamous cell lesions of the hamster cheek pouch. Bombesin increased, and RC-3095 decreased, phosphorylation in these samples. In the human hepatoma sample and surrounding tissue, these ligands altered the phosphorylation of the same substrates affected by EGF. EGF and bombesin stimulated phosphorylation synergistically in the hamster samples and the hepatoma. Bombesin-induced phosphorylation was greater in tissue surrounding the hepatoma, whereas RC-3095 was more effective in inhibiting phosphorylation in the hepatoma itself. This cancer, therefore, could be endogenously stimulated by gastrin-releasing peptide. These observations support the hypothesis that bombesin stimulates growth of tissues and tumors by amplifying the phosphorylation response to EGF. The growth inhibitory response to RC-3095, or other bombesin analogues, of individual tumors may be prognosed by in vitro phosphorylation assays using the samples from the patient's tumor

Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha-synuclein in oligodendrocytes

Mice overexpressing human alpha-synuclein in oligodendrocytes (MBP1-alpha-syn) recapitulate some key functional and neuropathological features of multiple system atrophy (MSA). Whether or not these mice develop severe autonomic failure, which is a key feature of human MSA, remains unknown. We explored cardiovascular autonomic regulation using long-term blood pressure (BP) radiotelemetry and pharmacological testing. We instrumented 12 MBP1-alpha-syn mice and 11 wild-type mice aged 9 months for radiotelemetry. Animals were tested with atropine, metoprolol, clonidine, and trimethaphan at 9 and 12 months age. We applied spectral and cross-spectral analysis to assess heart rate (HR) and BP variability. At 9 months of age daytime BP (transgenic: 101 +/- 2 vs. wild type: 99 +/- 2 mmHg) and HR (497 +/- 11 vs. 505 +/- 16 beats/min) were similar. Circadian BP and HR rhythms were maintained. Nighttime BP (109 +/- 2 vs. 108 +/- 2 mmHg) and HR (575 +/- 15 vs. 569 +/- 14 beats/min), mean arterial BP responses to trimethaphan (-21 +/- 8 vs. -10 +/- 5 mmHg, P = 0.240) and to clonidine (-8 +/- 3 vs. -5 +/- 2 mmHg, P = 0.314) were similar. HR responses to atropine (+159 +/- 24 vs. +146 +/- 22 beats/min), and to clonidine (-188 +/- 21 vs. -163 +/- 33 beats/min) did not differ between strains. Baroreflex sensitivity (4 +/- 1 vs. 4 +/- 1 msec/mmHg) and HR variability (total power, 84 +/- 17 vs. 65 +/- 21 msec(2)) were similar under resting conditions and during pharmacological testing. Repeated measurements at 12 months of age provided similar results. In mice, moderate overexpression of human alpha-synuclein in oligodendrocytes is not sufficient to induce overt autonomic failure. Additional mechanisms may be required to express the autonomic failure phenotype including higher levels of expression or more advanced age